A previous study found that the emergence of cdkn1a's antisense DNA damage‐activated RNA promoter as a conspicuous presence in tumour tissues renders it a key protagonist, additionally serving as an independent harbinger of OS in ccRCC.38 This evidence concerns the gene CDKN1A and nonpapillary renal cell carcinoma.